These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6104502)

  • 21. Technical background information report on carcinogenesis bioassay of 1,2-dibromoethane (EDB).
    Clin Toxicol; 1979 Apr; 14(4):473-8. PubMed ID: 380885
    [No Abstract]   [Full Text] [Related]  

  • 22. Aging as a confounding factor in carcinogenicity bioassays.
    von Wittenau MS; Gans DJ
    Drug Chem Toxicol; 1981; 4(4):307-10. PubMed ID: 7344908
    [No Abstract]   [Full Text] [Related]  

  • 23. [The carcinogenic and anticarcinogenic properties of neozon D].
    Pliss GB; Vlasov NN; Zabezhinskiĭ MA
    Vopr Onkol; 1991; 37(1):60-4. PubMed ID: 2014680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lancet-Oncology--a summary of the review on IARC carcinogens: metallic elements, dusts and fibers].
    Catalani S
    G Ital Med Lav Ergon; 2009; 31(2):182-3. PubMed ID: 19827280
    [No Abstract]   [Full Text] [Related]  

  • 25. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity.
    Gart JJ; Chu KC; Tarone RE
    J Natl Cancer Inst; 1979 Apr; 62(4):957-74. PubMed ID: 285297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenesis bioassay of 1,2-dichloroethane (EDC).
    Vet Hum Toxicol; 1980 Feb; 22(1):36-7. PubMed ID: 7361444
    [No Abstract]   [Full Text] [Related]  

  • 27. News about carcinogens: what's fit to print.
    Bloom BR
    Hastings Cent Rep; 1979 Aug; 9(4):5-7. PubMed ID: 489277
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible methods of carcinogenicity testing for substances used at the place of work.
    Steinhoff D
    Cancer Detect Prev; 1981; 4(1-4):41-6. PubMed ID: 7349803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental carcinogenesis: comment on methodlogy and interpretation of results.
    Pelfrene AF
    J Natl Cancer Inst; 1977 Mar; 58(3):475-7. PubMed ID: 839551
    [No Abstract]   [Full Text] [Related]  

  • 31. The in vivo rodent test systems for assessment of carcinogenic potential.
    van der Laan JW; Spindler P
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):122-5. PubMed ID: 11846641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fourteenth scientific meeting of the British Association of Surgical Oncology at the University College Hospital Medical School on Friday 7 December 1979. Abstracts of members' papers.
    Clin Oncol; 1980 Sep; 6(3):285-94. PubMed ID: 7428205
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings of The British Institute of Radiology. The combination of radiotherapy and chemotherapy. Abstracts of papers.
    Br J Radiol; 1979 Jul; 52(619):598-9. PubMed ID: 37969
    [No Abstract]   [Full Text] [Related]  

  • 34. Perinatal carcinogenesis: biologic curiosity or practical necessity?
    Clayson DB
    Natl Cancer Inst Monogr; 1979 May; (51):235-8. PubMed ID: 481576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical carcinogenesis studies in nonhuman primates.
    Adamson RH; Sieber SM
    Basic Life Sci; 1983; 24():129-56. PubMed ID: 6860262
    [No Abstract]   [Full Text] [Related]  

  • 36. Design of cancer assays for pharmaceutical agents: a reply.
    Boorman GA; Huff JE; Schwetz BA
    J Natl Cancer Inst; 1986 Aug; 77(2):589-90. PubMed ID: 3461218
    [No Abstract]   [Full Text] [Related]  

  • 37. APL-programs for the analysis of carcinogenicity experiments.
    Rosenkranz G
    Comput Programs Biomed; 1982 Oct; 15(2):87-91. PubMed ID: 6897218
    [No Abstract]   [Full Text] [Related]  

  • 38. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive and false-negative rates for carcinogenicity screens.
    Fears TR; Tarone RE; Chu KC
    Cancer Res; 1977 Jul; 37(7 Pt 1):1941-5. PubMed ID: 861930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental identification of genitourinary carcinogens.
    Sontag JM
    Urol Clin North Am; 1980 Oct; 7(3):803-14. PubMed ID: 6779409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.